[Toxicologic study on propiramfumarate. Summary of experimental results].
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000032:analysis; D000577:Amides / Q000633:toxicity*; D000700:Analgesics / Q000494:pharmacology / Q000633:toxicity*; D000818:Animals; D001070:Appetitive Behavior / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001786:Blood Glucose / Q000032:analysis; D001799:Blood Sedimentation; D001806:Blood Urea Nitrogen; D004353:Drug Evaluation, Preclinical; D004361:Drug Tolerance; D004622:Embryo, Mammalian / Q000187:drug effects; D004625:Embryo, Nonmammalian; D005260:Female; D005298:Fertility / Q000187:drug effects; D005650:Fumarates / Q000494:pharmacology / Q000633:toxicity; D006400:Hematocrit; D006452:Hemoglobinometry; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007958:Leukocyte Count; D008297:Male; D010880:Piperidines / Q000494:pharmacology / Q000633:toxicity; D011422:Propionates / Q000633:toxicity*; D011725:Pyridines / Q000494:pharmacology / Q000633:toxicity
D000577:Amides; D000700:Analgesics; D001786:Blood Glucose; D005650:Fumarates; D010880:Piperidines; D011422:Propionates; D011725:Pyridines; D000469:Alkaline Phosphatase
Toxikologische Untersuchungen mit Propiramfumarat. Zusammenfassung der Versuchsergebnisse